Product Information

TOBRAMYCIN 80 MG/2 ML VIAL is a generic product labeled by Hospira Inc., priced at $0.6528 per ML under NDC 00409357801. Its NADAC has been published 301 times since Nov 28, 2013.

The Low Outlier badge above means this manufacturer's average price in the TOBRAMYCIN market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

TOBRAMYCIN 80 MG/2 ML VIAL

TOBRAMYCIN
$0.6528per ML
Low Outlier

Strength

40 mg/mL

Manufacturer

Hospira Inc.

NDC

00409357801

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Last Updated

6/17/2026

Active Ingredients

TOBRAMYCIN SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA063111

On Market Since

5/5/2005

Pharmacological Classes

Price Statistics

The NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has been published 301 times since Nov 28, 2013, and over the history we have for it it has declined 48.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.6528 per ML
All-time high$1.4932 (Jan 15, 2014)
All-time low$0.5997 (Mar 18, 2026)
52-week high$0.8372
52-week low$0.5997
Median price$0.8495
Average price$0.8512
Largest weekly change+101.1% (Aug 20, 2014)
Weeks tracked301
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

+1.8%

3M

+8.9%

6M

-19.8%

1Y

-16.4%

3Y

-23.2%

5Y

-25.1%

All

-48.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the TOBRAMYCIN market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of TOBRAMYCIN 80 MG/2 ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for TOBRAMYCIN 80 MG/2 ML VIAL, manufactured by Hospira Inc., is $0.6528 per ML (NDC 00409357801), effective Jun 24, 2026.

How has the price of TOBRAMYCIN 80 MG/2 ML VIAL changed over time?

Over the history we have for it, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has declined 48.8%. It has been tracked across 301 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for TOBRAMYCIN 80 MG/2 ML VIAL?

Since Nov 28, 2013, the NADAC for TOBRAMYCIN 80 MG/2 ML VIAL has ranged from a low of $0.5997 (Mar 18, 2026) to a high of $1.4932 (Jan 15, 2014), with a median of $0.8495 per ML.

Are there cheaper alternatives to TOBRAMYCIN 80 MG/2 ML VIAL?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of TOBRAMYCIN 80 MG/2 ML VIAL, so no direct lower-cost alternative is listed.

Who manufactures TOBRAMYCIN 80 MG/2 ML VIAL?

TOBRAMYCIN 80 MG/2 ML VIAL (NDC 00409357801) is labeled by Hospira Inc., and CMS classifies it as a generic product.